• Effects of the symptom monitoring system on patient-reported quality of life related to cancer and cancer treatment [ Time Frame: Change from baseline quality of life at 12-months ]
  Quality of life will be assessed using a brief, validated 7-item patient-reported questionnaire (Functional Assessment of Cancer Therapy-General 7-item or FACT-G7) that asks about symptoms of fatigue, pain, and nausea, sleep quality and contentment with life.
• Effects of the symptom monitoring system on severity of patient-reported symptoms related to cancer and cancer treatment [ Time Frame: Change from baseline symptom severity at 12-months ]
  Symptom severity will be assessed via a Patient-Reported Outcome Measurement Information System (PROMIS) computer adaptive test (CAT) that will ask about depression, anxiety, pain, fatigue, and physical functioning. CAT items are dynamically selected for administration from an item bank based upon the respondent's previous answers. Patient usually completes 4-12 items with a high level of measurement.
• Effects of the symptom monitoring system on patient-reported adverse events related to cancer and cancer treatment [ Time Frame: Change from baseline adverse events at 12-months ]
  Adverse events will be assessed using the Patient-Reported Outcomes- Common Terminology Criteria for Adverse Events (PRO-CTCAE™) assessment. The PRO-CTCAE questionnaire will ask questions about nausea, constipation, insomnia, vomiting, and diarrhea.
• Impact of the symptom monitoring system on health care services used by patients [ Time Frame: Change from baseline use of healthcare services at 12 months ]
  Utilization of services related to physical and mental health will be measured using a patient-reported questionnaire to assess healthcare services used by participants, such as number of emergency room visits, oncology urgent care visits, general urgent care visits, doctor visits, referrals for services within and outside the health system, and overnight stays in the hospital.

• Effects of the symptom monitoring system on patient-reported quality of life related to cancer and cancer treatment [ Time Frame: Change from baseline quality of life at 12-months ]
  Quality of life will be assessed using a brief, validated 7-item patient-reported questionnaire (Functional Assessment of Cancer Therapy-General 7-item or FACT-G7) that asks about symptoms of fatigue, pain, and nausea, sleep quality and contentment with life.
• Effects of the symptom monitoring system on severity of patient-reported symptoms related to cancer and cancer treatment [ Time Frame: Change from baseline symptom severity at 12-months ]
  Symptom severity will be assessed via a Patient-Reported Outcome Measurement Information System (PROMIS) computer adaptive test (CAT) that will ask about depression, anxiety, pain, fatigue, and physical functioning. CAT items are dynamically selected for administration from an item bank based upon the respondent's previous answers. Patient usually completes 4-12 items with a high level of measurement.
• Effects of the symptom monitoring system on patient-reported adverse events related to cancer and cancer treatment [ Time Frame: Change from baseline adverse events at 12-months ]
  Adverse events will be assessed using the Patient-Reported Outcomes- Common Terminology Criteria for Adverse Events (PRO-CTCAE™) assessment. The PRO-CTCAE questionnaire will ask questions about nausea, constipation, insomnia, vomiting, shortness of breath, and diarrhea.
• Impact of the symptom monitoring system on health care services used by patients [ Time Frame: Change from baseline use of healthcare services at 12 months ]
  Utilization of services related to physical and mental health will be measured using a patient-reported questionnaire to assess healthcare services used by participants, such as number of emergency room visits, oncology urgent care visits, general urgent care visits, doctor visits, referrals for services within and outside the health system, and overnight stays in the hospital.

• Impact of the symptom monitoring system on patient experiences with their cancer care team [ Time Frame: Change from baseline patient experiences with their cancer care team at 12 months ]
  Patient experiences with their cancer care team will be measured using components of a standardized measure (Consumer Assessment of Healthcare Providers and Systems or CAHPS) designed to assess patient experiences with their healthcare provider and system.
• Patient experiences (barriers and facilitators) using the symptom and needs assessment [ Time Frame: Patient experiences will be assessed at one time point between baseline and 12 months ]
  Patient experiences with the symptom and needs assessment will be evaluated using qualitative methods (semi-structured interview or focus group)

Cancer patients' under-identified symptoms and concerns can result in treatment interference, poor care satisfaction, compromised health-related quality of life, and taxed healthcare systems. Cancer care organizations have emphasized the need for symptom assessment and management within quality cancer care delivery. We have leveraged health information technology to pilot and implement the Lurie Screening Initiative in the Robert H. Lurie Comprehensive Cancer Center (RHLCCC) within the Central region of Northwestern Medicine (NM). Following two pilot implementation projects, the screening initiative program is live in RHLCCC clinics. It allows patients to complete Patient Reported Outcomes Measurement Information System computer adaptive tests (PROMIS CATs) assessing depression, anxiety, fatigue, pain, and physical function, along with checklists of supportive care needs, within the electronic health record (EHR). Patients can do so at home via MyChart (a patient portal of their EHR) or in clinic via an EHR hyperlink. Assessment results immediately populate the EHR; severe symptoms and endorsed supportive care needs trigger notifications to clinicians (social workers, dieticians, oncologists & oncology nurses) who can then make referrals and care decisions in real time.

This study will expand and evaluate implementation of the screening initiative via these aims:

Aim 1. Evaluate the impact of system-wide implementation of the program on patient and system outcomes over 12 months via (a) a quality improvement study (estimated n=4,000 cases) to compare the impact of the program (versus usual care) on EHR-documented health care usage and patient satisfaction using a stepped wedge design in which clusters of study sites will gradually be assigned to cross from serving as a control to implementing the program and (b) a human subjects substudy (n=1,000) with patients who will complete the symptom monitoring and other patient-reported outcomes (PRO) measures of health care usage and satisfaction at baseline, 6 & 12 months. We will examine differences in PROs between participants whose screening responses trigger clinical alerts and those who do not. We will also explore longitudinal trajectories of PRO scores

Aim 3. Identify implementation facilitators and barriers to system-wide expansion of the program. We will conduct qualitative research to gather feedback from patients participating in the program expansion (n=50). This will include multiple assessments throughout implementation.

1. Must have medical chart confirmed diagnosis of a solid or hematological malignancy
2. Must have had oncology services at a Northwestern Medicine location within the past 12 months
3. Must have completed the current symptom monitoring assessment offered by Northwestern Medicine
4. Must be willing to complete electronic patient-reported measures (i.e. patient reported health care utilization and satisfaction surveys) at baseline, 6-month, and 12-month follow-up time points, and
5. Must consent to give authorized study staff access to details of their cancer diagnosis and treatment as documented in their electronic health record
6. If participating in a semi-structured interview or focus group, must consent to have their comments audio-recorded

Exclusion Criteria:

-